Literature DB >> 23785034

The gut microbiome in intestinal fibrosis: environmental protector or provocateur?

Florian Rieder1.   

Abstract

In individuals with inflammatory bowel diseases, intestinal fibrosis is a serious clinical complication with no specific therapies. Patients develop bowel fistulae and strictures that usually require surgery and often reoccur. The main driver of gut fibrogenesis is believed to be chronic inflammation, which leads to mesenchymal cell recruitment and activation. Recent findings suggest that the environment--in particular, the microbiome--plays a critical role in this process.

Entities:  

Mesh:

Year:  2013        PMID: 23785034      PMCID: PMC3823049          DOI: 10.1126/scitranslmed.3004731

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  59 in total

1.  Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease.

Authors:  Alessandro Armuzzi; Gert Van Assche; Walter Reinisch; Guillaume Pineton de Chambrun; Anne Griffiths; Malgorzata Sladek; Jan C Preiss; Milan Lukas; Geert D'Haens
Journal:  J Crohns Colitis       Date:  2012-03-09       Impact factor: 9.071

2.  Functional TLRs and NODs in human gingival fibroblasts.

Authors:  A Uehara; H Takada
Journal:  J Dent Res       Date:  2007-03       Impact factor: 6.116

3.  Activation of COL1A2 promoter in human fibroblasts by Escherichia coli.

Authors:  Haruko Miyazaki; Ryo Kobayashi; Hiroki Ishikawa; Naoki Awano; Satoshi Yamagoe; Yoshitsugu Miyazaki; Tetsuya Matsumoto
Journal:  FEMS Immunol Med Microbiol       Date:  2012-05-18

4.  Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1.

Authors:  Y Motomura; W I Khan; R T El-Sharkawy; M Verma-Gandhu; E F Verdu; J Gauldie; S M Collins
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

5.  Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.

Authors:  Ivan Monteleone; Angelamaria Rizzo; Massimiliano Sarra; Giuseppe Sica; Pierpaolo Sileri; Livia Biancone; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2011-04-16       Impact factor: 22.682

6.  Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.

Authors:  F Cominelli; C C Nast; B D Clark; R Schindler; R Lierena; V E Eysselein; R C Thompson; C A Dinarello
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

7.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

8.  Emergence of fibrocytes showing morphological changes in the inflamed colonic mucosa.

Authors:  Hirotsugu Uehara; Tomoo Nakagawa; Tatsuro Katsuno; Toru Sato; Atsushi Isono; Yoshiko Noguchi; Yasushi Saito
Journal:  Dig Dis Sci       Date:  2009-02-26       Impact factor: 3.199

Review 9.  Therapy for fibrotic diseases: nearing the starting line.

Authors:  Scott L Friedman; Dean Sheppard; Jeremy S Duffield; Shelia Violette
Journal:  Sci Transl Med       Date:  2013-01-09       Impact factor: 17.956

Review 10.  The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein.

Authors:  Robert Barouki; Xavier Coumoul; Pedro M Fernandez-Salguero
Journal:  FEBS Lett       Date:  2007-03-30       Impact factor: 4.124

View more
  21 in total

Review 1.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

2.  IL-17A Promotes Initiation and Development of Intestinal Fibrosis Through EMT.

Authors:  Hui-Jing Zhang; Yi-Ning Zhang; Huan Zhou; Lin Guan; Yue Li; Ming-Jun Sun
Journal:  Dig Dis Sci       Date:  2018-08-10       Impact factor: 3.199

3.  Role of intestinal myofibroblasts in HIV-associated intestinal collagen deposition and immune reconstitution following combination antiretroviral therapy.

Authors:  David M Asmuth; Irina V Pinchuk; Jian Wu; Gracie Vargas; Xiaoli Chen; Surinder Mann; Anthony Albanese; Zhong-Min Ma; Ramez Saroufeem; Gregory P Melcher; Paolo Troia-Cancio; Natalie J Torok; Christopher J Miller; Don W Powell
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

4.  Growth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice.

Authors:  Elizabeth A Jensen; Jonathan A Young; Zachary Jackson; Joshua Busken; Edward O List; Ronan K Carroll; John J Kopchick; Erin R Murphy; Darlene E Berryman
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

5.  Managing Intestinal Fibrosis in Patients With Inflammatory Bowel Disease.

Authors:  Florian Rieder
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-02

Review 6.  The two sides of the coin: Similarities and differences in the pathomechanisms of fistulas and stricture formations in irritable bowel disease.

Authors:  Michael Scharl; Ramona S Bruckner; Gerhard Rogler
Journal:  United European Gastroenterol J       Date:  2016-02-19       Impact factor: 4.623

Review 7.  Remodelling the extracellular matrix in development and disease.

Authors:  Caroline Bonnans; Jonathan Chou; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2014-12       Impact factor: 94.444

Review 8.  Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.

Authors:  Florian Rieder; Claudio Fiocchi; Gerhard Rogler
Journal:  Gastroenterology       Date:  2016-10-05       Impact factor: 22.682

Review 9.  Epithelial-mesenchymal transition in Crohn's disease.

Authors:  H Jiang; J Shen; Z Ran
Journal:  Mucosal Immunol       Date:  2017-12-20       Impact factor: 7.313

10.  Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease Cohort.

Authors:  Jonas Zeitz; Nicolas Fournier; Christian Labenz; Luc Biedermann; Pascal Frei; Benjamin Misselwitz; Sylvie Scharl; Stephan R Vavricka; Michael C Sulz; Michael Fried; Gerhard Rogler; Michael Scharl
Journal:  Inflamm Intest Dis       Date:  2017-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.